|
1
|
Monsel A, Zhu YG, Gudapati V, Lim H and
Lee JW: Mesenchymal stem cell derived secretome and extracellular
vesicles for acute lung injury and other inflammatory lung
diseases. Expert Opin Biol Ther. 16:859–871. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Wang LP and Tang XQ: Study on early
warning signals of acute lung injury. Life Sci Res. 25:532–539.
2021.
|
|
3
|
Zambon M and Vincent JL: Mortality rates
for patients with acute lung injury/ARDS have decreased over time.
Chest. 133:1120–1127. 2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Matthay MA, Zemans RL, Zimmerman GA, Arabi
YM, Beitler JR, Mercat A, Herridge M, Randolph AG and Calfee CS:
Acute respiratory distress syndrome. Nat Rev Dis Primers.
5(18)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Al Masry A, Boules ML, Boules NS and Ebied
RS: Optimal method for selecting PEEP level in ALI/ARDS patients
under mechanical ventilation. J Egypt Soc Parasitol. 42:359–372.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Fan E, Del Sorbo L, Goligher EC, Hodgson
CL, Munshi L, Walkey AJ, Adhikari NKJ, Amato MBP, Branson R, Brower
RG, et al: An official American thoracic society/European society
of intensive care medicine/society of critical care medicine
clinical practice guideline: Mechanical ventilation in adult
patients with acute respiratory distress syndrome. Am J Respir Crit
Care Med. 195:1253–1263. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Duggal A, Rezoagli E, Pham T, McNicholas
BA, Fan E, Bellani G, Rubenfeld G, Pesenti AM and Laffey JG: LUNG
SAFE Investigators and the ESICM Trials Group. Patterns of use of
adjunctive therapies in patients with early moderate to severe
ARDS: Insights from the LUNG SAFE study. Chest. 157:1497–1505.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Rosenberg OA: Pulmonary surfactant
preparations and surfactant therapy for ARDS in surgical intensive
care (a literature review). Creat Surg Oncol. 9:50–65. 2019.
|
|
9
|
Badet M, Bayle F, Richard JC and Guérin C:
Comparison of optimal positive end-expiratory pressure and
recruitment maneuvers during lung-protective mechanical ventilation
in patients with acute lung injury/acute respiratory distress
syndrome. Respir Care. 54:847–854. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fukuda Y: Acute lung injury/acute
respiratory distress syndrome: progress in diagnosis and treatment.
Topics: I. Pathogenesis and pathophysiology: 4. Pathophysiology and
histopathology of ALI/ARDS. Nihon Naika Gakkai Zasshi.
100:1536–1540. 2011.PubMed/NCBI View Article : Google Scholar : (In Japanese).
|
|
11
|
Zhang X, Zheng J, Yan Y, Ruan Z, Su Y,
Wang J, Huang H, Zhang Y, Wang W, Gao J, et al:
Angiotensin-converting enzyme 2 regulates autophagy in acute lung
injury through AMPK/mTOR signaling. Arch Biochem Biophys.
672(108061)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Su JS, Liu ES and Zhao XM: Advances in the
treatment of acute lung injury/acute respiratory distress syndrome
with traditional chinese medicine. Jilin J Tradit Chin Med.
(37)2019.(In Chinese).
|
|
13
|
Wang SB: Clinical characteristics and risk
factors of severe pneumonia in 165 cases of novel coronavirus
pneumonia. Chengdu University of TCM, 2021 (In Chinese).
|
|
14
|
Liu M: Effect of chuanfang no: L exposure
on COVID-19 a retrospective cohort study based on propensity score
matching. Chengdu University of TCM, 2021 (In Chinese).
|
|
15
|
Huang JH, Huang XH, Chen ZY, Zheng QS and
Sun RY: Dose conversion among different animals and healthy
volunteers in pharmacological study. Chin J Clin Pharmacol Ther.
9:1069–1072. 2004.
|
|
16
|
Arck PC: When 3 Rs meet a forth R:
Replacement, reduction and refinement of animals in research on
reproduction. J Reprod Immunol. 132:54–59. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kilkenny C, Browne W, Cuthill IC, Emerson
M and Altman DG: NC3Rs Reporting Guidelines Working Group. Animal
research: Reporting in vivo experiments: the ARRIVE guidelines. Br
J Pharmacol. 160:1577–1579. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang GQ: The effect and mechanism of
Lianggesan on fluid transportion in endotoxin acute lung injury
tissue. So Med Univ, 2014 (In Chinese).
|
|
19
|
Wang XH, Yan SG, Hui Y, Shi J and Li JT:
Mechanism of ephedrae Herba-rhei Radix et Rhizoma drug pair on
treating acute lung injury based on alveolar macrophage M2
polarization. Chin Tradit Herbal Drugs. 53:2715–2722. 2022.(In
Chinese).
|
|
20
|
Pei CX, Wang XM, Wu YC, Wang ZX, Huang DM,
Yang Q, et al: Studies on mechanism of platycodin D inhibiting
apoptosis and protecting acute lung injury via Bax/bcl-2/caspase-3
signaling pathway. Modernization Tradit Chin Med Materia
Medica-World Sci and Tech. 23:3551–3558. 2021.(In Chinese).
|
|
21
|
Mikawa K, Nishina K, Takao Y and Obara H:
ONO-1714, a nitric oxide synthase inhibitor, attenuates
endotoxin-induced acute lung injury in rabbits. Anesth Analg.
97:1751–1755. 2003.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Cumming G, Fidler F and Vaux DL: Error
bars in experimental biology. J Cell Biol. 177:7–11.
2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Huang X, Xiu H, Zhang S and Zhang G: The
role of macrophages in the pathogenesis of ALI/ARDS. Mediators
Inflamm. 2018(1264913)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Janz DR and Ware LB: Biomarkers of
ALI/ARDS: Pathogenesis, discovery, and relevance to clinical
trials. Semin Respir Crit Care Med. 34:537–548. 2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Bos LD, Martin-Loeches I and Schultz MJ:
ARDS: Challenges in patient care and frontiers in research. Eur
Respir Rev. 27(170107)2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Spieth PM and Zhang H: Pharmacological
therapies for acute respiratory distress syndrome. Curr Opin Crit
Care. 20:113–121. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhao R, Wang B, Wang D, Wu B, Ji P and Tan
D: Oxyberberine prevented lipopolysaccharide-induced acute lung
injury through inhibition of mitophagy. Oxid Med Cell Longev.
2021(6675264)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yu WY, Gao CX, Zhang HH, Wu YG and Yu CH:
Herbal active ingredients: potential for the prevention and
treatment of acute lung injury. Biomed Res Int.
2021(5543185)2021.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Hao X, Liu Y, Zhou P, Jiang Q, Yang Z, Xu
M, Liu S, Zhang S and Wang Y: Integrating network pharmacology and
experimental validation to investigate the mechanisms of
huazhuojiedu decoction to treat chronic atrophic gastritis. Evid
Based Complement Alternat Med. 2020(2638362)2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Li C: Multi-compound pharmacokinetic
research on Chinese herbal medicines: Approach and methodology.
Zhongguo Zhong Yao Za Zhi. 42:607–617. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
32
|
Li Z, Li WJ, Shang XY and Yu KY: Effect of
Zhenwu Decoction on myocardial mitochondrial damage and
cardiomyocyte apoptosis in heart failure rats by SIRT1 signaling
pathway. Chin Arch Tradit Chin Med. 36:1062–1067. 2018.(In
Chinese).
|
|
33
|
Wang YH, Li WJ and Li Z: Effect of serum
containing Zhenwu Decoction on cardiomyocyte apoptosis and Bcl-2
and Bax protein expression induced by isoproterenol in Rats.
Liaoning J Trad Chin Med. 45:1305–1308+1346. 2018.(In Chinese).
|
|
34
|
Yang PQ, Li QY and Fang S: Effect of
Zhenwu Decoction combined with Benazepril on the curative effect
and cardiopulmonary function of chronic pulmonary heart disease in
acute stage. J Emerg Trad Chin Med. 31:854–856. 2022.(In
Chinese).
|
|
35
|
Zhang Z, Zhao S, Han YP, Jin F, Shang JR,
Wang JP and Fang CY: Effect of Buyang Huanwu Decoction on
Keap1/Nrf2/HO-1 antioxidant signaling pathway in rats with
idiopathic pulmonary fibrosis. Chin J Exp Trad Med formula. 1–10,
(In Chinese).
|
|
36
|
National Pharmacopoeia Commission,
Pharmacopoeia of the People's Republic of China (2020 Edition),
China Medical Sciences Press, 2020.
|
|
37
|
Gao XM: Traditional Chinese pharmacy.
China Traditional Chinese Medicine Press, 2002-1.
|
|
38
|
Li H, Li Y, Song C, Hu Y, Dai M, Liu B and
Pan P: Neutrophil extracellular traps augmented alveolar macrophage
pyroptosis via AIM2 inflammasome activation in LPS-induced
ALI/ARDS. J Inflamm Res. 14:4839–4858. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Song C, Li H, Li Y, Dai M, Zhang L, Liu S,
Tan H, Deng P, Liu J, Mao Z, et al: NETs promote ALI/ARDS
inflammation by regulating alveolar macrophage polarization. Exp
Cell Res. 382(111486)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Chen H, Bai C and Wang X: The value of the
lipopolysaccharide-induced acute lung injury model in respiratory
medicine. Expert Rev Respir Med. 4:773–783. 2010.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Fujita M, Kuwano K, Kunitake R, Hagimoto
N, Miyazaki H, Kaneko Y, Kawasaki M, Maeyama T and Hara N:
Endothelial cell apoptosis in lipopolysaccharide-induced lung
injury in mice. Int Arch Allergy Immunol. 117:202–208.
1998.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Fukatsu M, Ohkawara H, Wang X, Alkebsi L,
Furukawa M, Mori H, Fukami M, Fukami SI, Sano T, Takahashi H, et
al: The suppressive effects of Mer inhibition on inflammatory
responses in the pathogenesis of LPS-induced ALI/ARDS. Sci Signal.
15(eabd2533)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Li N, Geng C, Hou S, Fan H and Gong Y:
Damage-associated molecular patterns and their signaling pathways
in primary blast lung injury: New research progress and future
directions. Int J Mol Sci. 21(6303)2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang G, Han D, Zhang Y, Xie X, Wu Y, Li S
and Li M: A novel hypothesis: Up-regulation of HO-1 by activation
of PPARγ inhibits HMGB1-RAGE signaling pathway and ameliorates the
development of ALI/ARDS. J Thorac Dis. 5:706–710. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Xu Y, Li J, Lin Z, Liang W, Qin L, Ding J,
Chen S and Zhou L: Isorhamnetin alleviates airway inflammation by
regulating the Nrf2/Keap1 pathway in a mouse model of COPD. Front
Pharmacol. 13(860362)2022.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Meyer A, Zoll J, Charles AL, Charloux A,
de Blay F, Diemunsch P, Sibilia J, Piquard F and Geny B: Skeletal
muscle mitochondrial dysfunction during chronic obstructive
pulmonary disease: Central actor and therapeutic target. Exp
Physiol. 98:1063–1078. 2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Bouitbir J, Charles AL, Echaniz-Laguna A,
Kindo M, Daussin F, Auwerx J, Piquard F, Geny B and Zoll J:
Opposite effects of statins on mitochondria of cardiac and skeletal
muscles: A ‘mitohormesis’ mechanism involving reactive oxygen
species and PGC-1. Eur Heart J. 33:1397–1407. 2012.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Yu J, Wang Y, Li Z, Dong S, Wang D, Gong
L, Shi J, Zhang Y, Liu D and Mu R: Effect of heme oxygenase-1 on
mitofusin-1 protein in LPS-induced ALI/ARDS in rats. Sci Rep.
6(36530)2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Lee SY, Li MH, Shi LS, Chu H, Ho CW and
Chang TC: Rhodiola crenulata extract alleviates hypoxic pulmonary
edema in rats. Evid Based Complement Alternat Med.
2013(718739)2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Balamurugan K: HIF-1 at the crossroads of
hypoxia, inflammation, and cancer. Int J Cancer. 138:1058–1066.
2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Eltzschig HK and Carmeliet P: Hypoxia and
inflammation. N Engl J Med. 364:656–665. 2011.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Devraj G, Beerlage C, Brüne B and Kempf
VA: Hypoxia and HIF-1 activation in bacterial infections. Microbes
Infect. 19:144–156. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Cummins EP, Keogh CE, Crean D and Taylor
CT: The role of HIF in immunity and inflammation. Mol Aspects Med.
47-48:24–34. 2016.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Zhao J, Jiang P, Guo S, Schrodi SJ and He
D: Apoptosis, autophagy, NETosis, necroptosis, and pyroptosis
mediated programmed cell death as targets for innovative therapy in
rheumatoid arthritis. Front Immunol. 12(809806)2021.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Van Opdenbosch N and Lamkanfi M: Caspases
in cell death, inflammation, and disease. Immunity. 50:1352–1364.
2019.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Kesavardhana S, Malireddi RKS and
Kanneganti TD: Caspases in cell death, inflammation, and
pyroptosis. Annu Rev Immunol. 38:567–595. 2020.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Liu X, Gao C, Wang Y, Niu L, Jiang S and
Pan S: BMSC-derived exosomes ameliorate LPS-induced acute lung
injury by miR-384-5p-controlled alveolar macrophage autophagy. Oxid
Med Cell Longev. 2021(9973457)2021.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Wu D, Zhang H, Wu Q, Li F, Wang Y, Liu S
and Wang J: Sestrin 2 protects against LPS-induced acute lung
injury by inducing mitophagy in alveolar macrophages. Life Sci.
267(118941)2021.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Zhao X, Yu Z, Lv Z, Meng L, Xu J, Yuan S
and Fu Z: Activation of alpha-7 nicotinic acetylcholine receptors
(α7nAchR) promotes the protective autophagy in LPS-induced acute
lung injury (ALI) in vitro and in vivo. Inflammation. 42:2236–2245.
2019.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ning L, Wei W, Wenyang J, Rui X and Qing
G: Cytosolic DNA-STING-NLRP3 axis is involved in murine acute lung
injury induced by lipopolysaccharide. Clin Transl Med.
10(e228)2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Klionsky DJ, Codogno P, Cuervo AM, Deretic
V, Elazar Z, Fueyo-Margareto J, Gewirtz DA, Kroemer G, Levine B,
Mizushima N, et al: A comprehensive glossary of autophagy-related
molecules and processes. Autophagy. 6:438–448. 2010.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Alers S, Löffler AS, Wesselborg S and
Stork B: Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy:
Cross talk, shortcuts, and feedbacks. Mol Cell Biol. 32:2–11.
2012.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Tanida I, Ueno T and Kominami E: LC3 and
autophagy. Methods Mol Biol. 445:77–88. 2008.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Mizushima N and Levine B: Autophagy in
human diseases. N Engl J Med. 383:1564–1576. 2020.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Qu L, Chen C, He W, Chen Y, Li Y, Wen Y,
Zhou S, Jiang Y, Yang X, Zhang R and Shen L: Glycyrrhizic acid
ameliorates LPS-induced acute lung injury by regulating autophagy
through the PI3K/AKT/mTOR pathway. Am J Transl Res. 11:2042–2055.
2019.PubMed/NCBI
|
|
67
|
Wei F, Jiang X, Gao HY and Gao SH:
Liquiritin induces apoptosis and autophagy in cisplatin
(DDP)-resistant gastric cancer cells in vitro and xenograft
nude mice in vivo. Int J Oncol. 51:1383–1394.
2017.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Dikic I and Elazar Z: Mechanism and
medical implications of mammalian autophagy. Nat Rev Mol Cell Biol.
19:349–364. 2018.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Masuda GO, Yashiro M, Kitayama K, Miki Y,
Kasashima H, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T,
Sakurai K, et al: Clinicopathological correlations of
autophagy-related proteins LC3, beclin 1 and p62 in gastric cancer.
Anticancer Res. 36:129–136. 2016.PubMed/NCBI
|
|
70
|
Fan TJ, Han LH, Cong RS and Liang J:
Caspase family proteases and apoptosis. Acta Biochim Biophys Sin
(Shanghai). 37:719–727. 2005.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Zhang Y, Yang X, Ge X and Zhang F:
Puerarin attenuates neurological deficits via Bcl-2/Bax/cleaved
caspase-3 and Sirt3/SOD2 apoptotic pathways in subarachnoid
hemorrhage mice. Biomed Pharmacother. 109:726–733. 2019.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Choudhary GS, Al-Harbi S and Almasan A:
Caspase-3 activation is a critical determinant of genotoxic
stress-induced apoptosis. Methods Mol Biol. 1219:1–9.
2015.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Schroder K and Tschopp J: The
inflammasomes. Cell. 140:821–832. 2010.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Zhang ZQ and Sun LL: Clinical significance
of IL-1β and IL-18 in acute lung injury. Hainan Med J.
28:1954–1956. 2017.(In Chinese).
|
|
75
|
McVey MJ, Steinberg BE and Goldenberg NM:
Inflammasome activation in acute lung injury. Am J Physiol Lung
Cell Mol Physiol. 320:L165–L178. 2021.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Karmakar M, Minns M, Greenberg EN,
Diaz-Aponte J, Pestonjamasp K, Johnson JL, Rathkey JK, Abbott DW,
Wang K, Shao F, et al: N-GSDMD trafficking to neutrophil organelles
facilitates IL-1β release independently of plasma membrane pores
and pyroptosis. Nat Commun. 11(2212)2020.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Shi J, Gao W and Shao F: Pyroptosis:
Gasdermin-mediated programmed necrotic cell death. Trends Biochem
Sci. 42:245–254. 2017.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Liu Y, Zhou J, Luo Y, Li J, Shang L, Zhou
F and Yang S: Honokiol alleviates LPS-induced acute lung injury by
inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2
activation in vitro and in vivo. Chin Med. 16(127)2021.PubMed/NCBI View Article : Google Scholar
|
|
79
|
D'Arcy MS: Cell death: A review of the
major forms of apoptosis, necrosis and autophagy. Cell Biol Int.
43:582–592. 2019.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Tan S and Chen S: The mechanism and effect
of autophagy, apoptosis, and pyroptosis on the progression of
silicosis. Int J Mol Sci. 22(8110)2021.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Ge Y, Xu X, Liang Q, Xu Y and Huang M:
α-Mangostin suppresses NLRP3 inflammasome activation via promoting
autophagy in LPS-stimulated murine macrophages and protects against
CLP-induced sepsis in mice. Inflamm Res. 68:471–479.
2019.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Wong WT, Li LH, Rao YK, Yang SP, Cheng SM,
Lin WY, Cheng CC, Chen A and Hua KF: Repositioning of the β-blocker
carvedilol as a novel autophagy inducer that inhibits the NLRP3
inflammasome. Front Immunol. 9(1920)2018.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Guo R, Wang H and Cui N: Autophagy
regulation on pyroptosis: Mechanism and medical implication in
sepsis. Mediators Inflamm. 2021(9925059)2021.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Fernández A, Ordóñez R, Reiter RJ,
González-Gallego J and Mauriz JL: Melatonin and endoplasmic
reticulum stress: Relation to autophagy and apoptosis. J Pineal
Res. 59:292–307. 2015.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Ma C, Zhang D, Ma Q, Liu Y and Yang Y:
Arbutin inhibits inflammation and apoptosis by enhancing autophagy
via SIRT1. Adv Clin Exp Med. 30:535–544. 2021.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Nakahira K, Cloonan SM, Mizumura K, Choi
AMK and Ryter SW: Autophagy: A crucial moderator of redox balance,
inflammation, and apoptosis in lung disease. Antioxid Redox Signal.
20:474–494. 2014.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Changle Z, Cuiling F, Feng F, Xiaoqin Y,
Guishu W, Liangtian S and Jiakun Z: Baicalin inhibits inflammation
of lipopolysaccharide-induced acute lung injury toll like
receptor-4/myeloid differentiation primary response 88/nuclear
factor-kappa B signaling pathway. J Tradit Chin Med. 42:200–212.
2022.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Liu Z, Wang P, Lu S, Guo R, Gao W, Tong H,
Yin Y, Han X, Liu T, Chen X, et al: Liquiritin, a novel inhibitor
of TRPV1 and TRPA1, protects against LPS-induced acute lung injury.
Cell Calcium. 88(102198)2020.PubMed/NCBI View Article : Google Scholar : (Epub ahead of
print).
|
